Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VHLL anticorps (N-Term)

Cet anticorps Lapin Polyclonal détecte spécifiquement VHLL dans WB. Il présente une réactivité envers Humain.
N° du produit ABIN2791981

Aperçu rapide pour VHLL anticorps (N-Term) (ABIN2791981)

Antigène

Voir toutes VHLL Anticorps
VHLL (Von Hippel-Lindau Tumor Suppressor-Like (VHLL))

Reactivité

Humain

Hôte

  • 6
  • 3
Lapin

Clonalité

  • 7
  • 2
Polyclonal

Conjugué

  • 5
  • 2
  • 1
  • 1
Cet anticorp VHLL est non-conjugé

Application

  • 6
  • 3
  • 1
Western Blotting (WB)
  • Épitope

    • 6
    • 1
    • 1
    • 1
    • 1
    N-Term

    Séquence

    PWRAGNGVGL EAQAGTQEAG PEEYCQEELG AEEEMAARAA WPVLRSVNSR

    Homologie

    Human: 100%

    Attributs du produit

    This is a rabbit polyclonal antibody against VHLL. It was validated on Western Blot.

    Purification

    Affinity Purified

    Immunogène

    The immunogen is a synthetic peptide directed towards the N-terminal region of Human VHLL
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeat freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
  • Antigène

    VHLL (Von Hippel-Lindau Tumor Suppressor-Like (VHLL))

    Autre désignation

    VHLL

    Sujet

    Von Hippel-Lindau (VHL) tumor suppressor protein is a component of an E3 ubiquitin ligase complex that selectively ubiquitinates the alpha subunit of the hypoxia-inducible factor (HIF) transcription factor for proteasome-mediated degradation. Inactivation of VHL causes VHL disease and sporadic kidney cancer. This gene encodes a VHL homolog that lacks one of two key domains necessary for VHL function. This gene may contribute to the regulation of oxygen homeostasis and neovascularization during placenta development. This gene is intronless, and can also be interpreted as a retrotransposed pseudogene of the VHL locus located on chromosome 3. However, the protein is represented in this RefSeq due to evidence in PMID:14757845 that strongly suggests it is translated. The same publication also indicates that this protein binds HIF alpha but fails to recruit the E3 ubiquitin ligase complex, and it therefore functions as a dominant-negative VHL protein and a protector of HIF alpha.
    Alias Symbols: VHLP, VLP
    Protein Interaction Partner: RBPMS, DAZAP2, HIF1A,
    Protein Size: 139

    Poids moléculaire

    15 kDa

    ID gène

    391104

    NCBI Accession

    NM_001004319, NP_001004319

    UniProt

    Q6RSH7
Vous êtes ici:
Chat with us!